SCHEMBL6181722

SCHEMBL6181722

O=C(c1cc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)nc2ccc(F)cc12)N1CCC(N2CCC[C@@H](C(=O)N3CCOCC3)C2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.51
ACACA Q13085 1/20 0.51
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
CYP2C9 P11712 3/20 0.44
ALDH1A1 P00352 5/20 0.43
TSHR P16473 2/20 0.43
LMNA P02545 1/20 0.43
TRPV1 Q8NER1 2/20 0.42
MOK Q9UQ07 2/20 0.42
KDM4E B2RXH2 4/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
GAA P10253 1/20 0.41
ATM Q13315 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
POLB P06746 2/20 0.41
USP2 O75604 1/20 0.41
TP53 P04637 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6183549 0.89 ACACB (0.53) ACACBACACAMEN1KMT2ACYP2C9
SCHEMBL6183582 0.88 ACACB (0.52) ACACBACACAMEN1KMT2ACYP2C9
SCHEMBL6184827 0.85 ACACB (0.55) ACACBACACAMEN1KMT2ACYP2C9
SCHEMBL6185309 0.84 ACACB (0.53) ACACBACACAMEN1KMT2ACYP2C9
SCHEMBL6182985 0.80 MOK (0.48) ACACBACACAMEN1KMT2ACYP2C9
SCHEMBL6183490 0.79 ALDH1A1 (0.58) ACACBACACAMEN1KMT2ACYP2C9
SCHEMBL6184192 0.78 ACACB (0.51) ACACBACACAMEN1KMT2ACYP2C9
SCHEMBL977857 0.75 ACACB (0.51) ACACBACACACYP2C9ALDH1A1TSHR
SCHEMBL6182950 0.73 ACACB (0.55) ACACBACACAMEN1KMT2ACYP2C9
SCHEMBL977472 0.73 ACACB (0.71) ACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6979741-B2 Acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2005-12-27 US disclosed
EP-1478437-B1 ACC INHIBITORS PFIZER PROD INC (US) 2005-08-31 EP disclosed
US-20030187254-A1 Acetyl-CoA carboxylase inhibitors PFIZER INC. 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187254-A1 Acetyl-CoA carboxylase inhibitors ACACA, ACACB, ACAT1 ACACB 2/4885ACACA 1/4885MEN1 3712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.